Du benytter en nettleser vi ikke støtter. Se informasjon om nettlesere

6. Referanser

Aanonsen N, red. ADHD. Diagnose, klinikk og behandling hos voksne. Gyldendal akademisk; 2000.
Abel KF, Bramness JG, Martinsen EW. Stimulant medication for ADHD in opioid maintenance treatment. Journal of dual diagnosis 2014;10(1):32-8.
Adler LA, Spencer TJ, Williams DW, Moore RJ, Michelson D. Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study2008.
AGREE Collaboration S-oh. Evaluering av faglige retningslinjer : AGREE instrumentet. Oslo: Helsedirektoratet; 2003. Tilgjengelig fra: www.agreetrust.org/index.aspx?o=1414
Akershus universitetssykehus. Utredning og behandling av ADHD hos voksne. 2014.
American Psyciathric Association. Diagnostic and statistical manual of mental disorders. 2. utgave utg. Washington, DC; 1968.
American Psyciathric Association. Diagnostic and statistical manual of mental disorders. 3rd utg. Washington, DC; 1980.
American Psyciathric Association. Diagnostic and statistical manual of mental disorders. Fifth Edition utg. Washington, DC; 2013.
American Psyciathric Association. Diagnostic and statistical manual of mental disorders. Fourth Edition Text Revisions utg. Washington, DC; 2000.
American Psyciathric Association. Diagnostic and statistical manual of mental disorders. Fourth Edition utg. Washington, DC; 1994.
American Psyciathric Association. Diagnostic and statistical manual of mental disorders. Third Edition Revised utg. Washington, DC; 1987.
Amlund-Hagen K, Ogden T, Bjørnebekk G. Treatment outcomes and mediators of Parent Management Training: A one-year follow-up of children with conduct problems. J Clin Child Adolesc Psychology 2011; 40(2):1-14.
Antshel KM, Kaul P, Biederman J, Spencer TJ, Hier BO, Hendricks K, et al. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission. J Clin Psychiatry 2013;74(3):e197-204.
Arnold LE, Hodgkins P, Kahle J, Madhoo M, Kewley G. Long-Term Outcomes of ADHD: Academic Achievement and Performance. Journal of attention disorders 2015.
Arns M, Heinrich H, Strehl U. Evaluation of neurofeedback in ADHD: the long and winding road. Biol Psychol 2014;95:108-15.
Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 2004;4(1):38.
Bai G, Wang Y, Yang L, Niu W. Effectiveness of a focused, brief psychoeducation program for parents of ADHD children: improvement of medication adherence and symptoms. Neuropsychiatric Dis and Treat 2015;11 2721–35.
Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr 2006;27(1):1-10.
Barkley R, Murphy K, Fischer M. ADHD in adults: what the science says. New York: Guildford Press; 2008.
Barkley R. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd edition utg.: Guilford Press; 2005.
Bergensklinikkene S, red. Svarstad S, Dahl T. Erfaringsrapport fra nasjonal konferanse om kombinasjonsbehandling med sentralstimulerende medikament for pasienter med ADHD som mottar legemiddelassistert rehabilitering (LAR). Bergen2010.
Biederman J, Faraone SV, Monuteaux MC, Bober M, Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry 2004;55(7):692-700.
Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157(5):816-8.
Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV. Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 2012;73(7):941-50.
Bjorgaas HM, Hysing M, Elgen I. Psychiatric disorders among children with cerebral palsy at school starting age. Res Dev Disabil 2012;33(4):1287-93.
Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 2009;48(9):884-93.
Bufferd SJ, Dougherty LR, Carlson GA, Rose S, Klein DN. Psychiatric disorders in preschoolers: continuity from ages 3 to 6. Am J Psychiatry 2012;169(11):1157-64.
Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;69(12):1160-7.
Charach A, Yeung E, Climans T, Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011;50(1):9-21.
coachforening Dn. Hva er coaching? [lest]. Tilgjengelig fra: http://www.coachforening.no/hva-er-coaching.html
Cortese S, Brown TE, Corkum P, Gruber R, O'Brien LM, Stein M, et al. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2013;52(8):784-96.
Daley D, Birchwood J. ADHD and academic performance: why does ADHD impact on academic performance and what can be done to support ADHD children in the classroom? Child Care Health Dev 2010;36(4):455-64.
Dittmann RW, Cardo E, Nagy P, Anderson CS, Bloomfield R, Caballero B, et al. Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS drugs 2013;27(12):1081-92.
DIVA Stiftelse. DIVA 2.0 (Diagnostisk intervju for utredning av ADHD hos voksne. Norsk utgave utg.2010.
Dougherty LR, Smith VC, Bufferd SJ, Carlson GA, Stringaris A, Leibenluft E, et al. DSM-5 disruptive mood dysregulation disorder: correlates and predictors in young children. Psychol Med 2014:1-12.
DuPaul G, Power T, Anastopoulos A, Reid R. ADHD Rating Scale - IV. New York: The Guilford Press; 1998.
Duric NS, Assmus J, Gundersen D, Elgen IB. Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports. BMC Psychiatry 2012;12:107.
Egeland J, Aarlien AK, Saunes BK. Few effects of far transfer of working memory training in ADHD: a randomized controlled trial. PLoS One 2013;8(10):e75660.
Elgen I, Sommerfelt K, Markestad T. Population based, controlled study of behavioural problems and psychiatric disorders in low birthweight children at 11 years of age. Arch Dis Child Fetal Neonatal Ed 2002;87(2):F128-32.
European Medicines Agency. Committee for Medicinal Products for Human Use. Elements recommended for inclusion in Summaries of Product Characteristics for methylphenidate-containing medicinal products authorised for the treatment of ADHD in children aged six years and above and adolescents. Use CfMPfH; 209. Tilgjengelig fra: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Methylphenidate_31/WC500011184.pdf
Falkmyr Ø, Egeland J. Psykometriske egenskaper for den norske versjonen av Behavior Inventory of Executive Function (BRIEF). Tidsskrift for Norsk Psykologforening 2011;48(4):339-43.
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57(11):1313-23.
Fernell E, Nylander L, Kadesjo B, Gillberg C. [ADHD should be given more attention--early interventions prevents unnecessary suffering]. Lakartidningen 2014;111(39):1652-55.
Ferrin M, Perez-Ayala V, El-Abd S, Lax-Pericall T, Jacobs B, Bilbow A, Taylor E. A randomized controlled trial evaluating the efficacy of a psychoeducation program for families of children and adolescents with ADHD in the United Kingdom: Results after a 6-month follow-up. J Atten Disord 2016; Feb 2. pii: 1087054715626509. [Epub ahead of print].
Fletcher JM. The effects of childhood ADHD on adult labor market outcomes. Health Econ 2014;23(2):159-81.
Forskrift om habilitering og rehabilitering, individuell plan og koordinator. FOR 2011-12-16 nr 1256.
Forskrift om pasientjournal. FOR-2000-12-21-1385.
Fossum S, Morch WT, Handegard BH, Drugli MB, Larsson B. Parent training for young Norwegian children with ODD and CD problems: predictors and mediators of treatment outcome. Scand J Psychol 2009;50(2):173-81.
Fredriksen M, Dahl AA, Martinsen EW, Klungsoyr O, Haavik J, Peleikis DE. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity. Eur Neuropsychopharmacol 2014;24(12):1873-84.
Fredriksen M, Halmoy A, Faraone SV, Haavik J. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. Eur Neuropsychopharmacol 2013;23(6):508-27.
Furlong M, McGilloway S, Bywater T, Hutchings J, Smith SM, Donnelly M. Cochrane review: behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years (Review). Evidence-based child health : a Cochrane review journal 2013;8(2):318-692.
Garløv I, Weidle B, Sommerschild H, Grøholt B, red. Lærebok i barnepsykiatri. 5. utgave utg.: Universitetsforlaget; 2015.
Garnock-Jones KP, Keating GM. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 2009;11(3):203-26.
Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br J Psychiatry 2002;181:22-8.
Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, et al. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry 2009;50(7):780-9.
Gillberg C. Clinical Child Neuropsychiatry. Cambridge University Press; 1995.
Gillberg C. The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations. Res Dev Disabil 2010;31(6):1543-51.
Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord 2014;16(3).
Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior rating inventory of executive function. Child Neuropsychol 2000;6(3):235-8.
Gjevik E, Eldevik S, Fjaeran-Granum T, Sponheim E. Kiddie-SADS reveals high rates of DSM-IV disorders in children and adolescents with autism spectrum disorders. J Autism Dev Disord 2011;41(6):761-9.
Goodman A, Heiervang E, Collishaw S, Goodman R. The 'DAWBA bands' as an ordered-categorical measure of child mental health: description and validation in British and Norwegian samples. Soc Psychiatry Psychiatr Epidemiol 2011;46(6):521-32.
Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry 2001;40(2):180-7.
Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, et al. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study. Addiction 2013;108(8):1503-11.
Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, et al. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry 2013;203(2):112-9.
Gropper RJ, Gotlieb H, Kronitz R, Tannock R. Working memory training in college students with ADHD or LD. Journal of attention disorders 2014;18(4):331-45.
Heiervang E, Stormark KM, Lundervold AJ, Heimann M, Goodman R, Posserud MB, et al. Psychiatric disorders in Norwegian 8- to 10-year-olds: an epidemiological survey of prevalence, risk factors, and service use. J Am Acad Child Adolesc Psychiatry 2007;46(4):438-47.
Heilskov Rytter MJ, Andersen LB, Houmann T, Bilenberg N, Hvolby A, Molgaard C, et al. Diet in the treatment of ADHD in children - a systematic review of the literature. Nordic journal of psychiatry 2015;69(1):1-18.
Helsedirektoratet S-o. Veileder i diagnostikk og behandling av AD/HD : diagnostikk og behandling av hyperkinetisk forstyrrelse/attention deficit hyperactivity disorder (AD/HD) hos barn, ungdom og voksne. Revidert utgave utg. Oslo, Norway: 2007.
Helsedirektoratet. Nasjonale retningslinjer for diagnostisering og behandling av voksne med depresjon i primær- og spesialisthelsetjenesten. Oslo; 2009.
Helsedirektoratet. Nasjonale retningslinjer for forebygging av selvmord i psykisk helsevern. Oslo; 2008.
Helsedirektoratet. Utvikling av kunnskaopsbaserte retningnslinjer. Oslo, Norway: Helsedirektoratet; 2012. IS-1870. Tilgjengelig fra: http://www.helsedirektoratet.no
Huang YS, Tsai MH. Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge. CNS drugs 2011;25(7):539-54.
Hysing M, Bøe T. Måleegenskaper ved den norske versjonen av Fem til Femten (5-15). PsykTestBARN 2013;(1):3.
Indredavik MS, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk AM. Psychiatric symptoms and disorders in adolescents with low birth weight. Arch Dis Child Fetal Neonatal Ed 2004;89(5):F445-50.
Jacob CP, Gross-Lesch S, Reichert S, Geissler J, Jans T, Kittel-Schneider S, et al. Sex- and Subtype-Related Differences of Personality Disorders (Axis II) and Personality Traits in Persistent ADHD. Journal of attention disorders 2014.
Kadesjo B, Janols LO, Korkman M, Mickelsson K, Strand G, Trillingsgaard A, et al. The FTF (Five to Fifteen): the development of a parent questionnaire for the assessment of ADHD and comorbid conditions. Eur Child Adolesc Psychiatry 2004;13 Suppl 3:3-13.
Kamal M, Bener A, Ehlayel MS. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? Attention deficit and hyperactivity disorders 2014;6(2):73-8.
Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35(2):245-56.
Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012;69(12):1295-303.
Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlstrom K, et al. Computerized training of working memory in children with ADHD--a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2005;44(2):177-86.
Knouse LE, Safren SA. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33(3):497-509.
Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010;10:67.
Korkman M, Jaakkola M, Ahlroth A, Pesonen AE, Turunen MM. Screening of developmental disorders in five-year-olds using the FTF (Five to Fifteen) questionnaire: a validation study. Eur Child Adolesc Psychiatry 2004;13 Suppl 3:31-8.
Kornør H, Bøe T. Måleegenskaper ved den norske versjonen av ADHD Rating Scale IV, Skoleversjon (ADHD-RS-IV Skole). PsykTestBARN 2011;1:9.
Kornør H, Bøe T. Måleegenskaper ved den norske versjonen av ADHD-RS-IV – ADHD Rating scale – IV Hjemmeversjon (ADHD-RS-IV Hjemme). PsykTestBARN 2011;1:8.
Kornør H, Hysing M. Måleegenskaper ved den norske versjonen av Adult ADHD Self Report Scale, 1.1 (ASRS). PsykTestBARN 2011;(1):6.
Kubik JA. Efficacy of ADHD coaching for adults with ADHD. Journal of attention disorders 2010;13(5):442-53.
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention deficit and hyperactivity disorders 2010;2(4):241-55.
Langley K, Fowler T, Ford T, Thapar AK, van den Bree M, Harold G, et al. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 2010;196(3):235-40.
Larsson B, Fossum S, Clifford G, Drugli MB, Handegard BH, Morch WT. Treatment of oppositional defiant and conduct problems in young Norwegian children : results of a randomized controlled trial. Eur Child Adolesc Psychiatry 2009;18(1):42-52.
Law EC, Sideridis GD, Prock LA, Sheridan MA. Attention-deficit/hyperactivity disorder in young children: predictors of diagnostic stability. Pediatrics 2014;133(4):659-67.
Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S. Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey. J Clin Psychiatry 2013;74(1):e87-93.
Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S. Psychopharmacological treatment of ADHD in adults aged 50+: an empirical study. Journal of attention disorders 2015;19(5):380-9.
Lerner MD, Mikami AY, McLeod BD. The alliance in a friendship coaching intervention for parents of children with ADHD. Behav Ther 2011;42(3):449-61.
Lov om etablering og gjennomføring av psykisk helsevern (psykisk helsevernloven). LOV-1999-07-02-62.
Lov om folketrygd (folketrygdloven). LOV-1997-02-28-19.
Lov om grunnskolen og den vidaregåande opplæringa (opplæringslova). LOV 1998-07-17-61.
Lov om helsepersonell m.v. LOV 1999-07-02-64.
Lov om kommunale helse- og omsorgstjenester m.m. LOV 2011-06-24-30.
Lov om pasient og brukerrettigheter (pasient - og brukerrettighetsloven). LOV 1999-07-02-63.
Lov om spesialisthelsetjenesten m.m. (spesialisthelsetjenesteloven). LOV 1999-07-02-61.
Lovisenberg Diakonale Sykehus. Behandlingslinje for barn og unge med AD/HD i Oslo. 2010.
Läkemedelsverket. Läkemedelsbehandling av ADHD - ny rekommendation. Information från Läkemedelsverket 2009;20(1):11.
Martel MM. Research review: a new perspective on attention-deficit/hyperactivity disorder: emotion dysregulation and trait models. J Child Psychol Psychiatry 2009;50(9):1042-51.
McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004;161(11):1948-56.
Meisel V, Servera M, Garcia-Banda G, Cardo E, Moreno I. Reprint of "Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up". Biol Psychol 2014;95:116-25.
Meltzer A, Steinbakk E. Et veiledningsprogram for foreldre til barn med ADHD. Tidsskr Nor Psykol 2006;43(2):105-12.
Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002;41(4):378-85.
Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009;48(5):484-500.
Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. Eur Psychiatry 2011;26(3):166-75.
Nasjonal faglig retningslinje for utredning, behandling og oppfølging av personer med samtidig ruslidelse og psykisk lidelse - ROP-lidelser. Oslo: Helsedirektoratet; 2012.
National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder (ADHD): diagnosis and management of ADHD in children, young people and adults. London, United Kingdom: 2008. National Clinical Practice Guideline Number 72. Tilgjengelig fra: ttp://guidance.nice.org.uk/CG72
Nigg JT, Craver L. Commentary: ADHD and social disadvantage: an inconvenient truth? --a reflection on Russell et al. () and Larsson et al. (). J Child Psychol Psychiatry 2014;55(5):446-7.
Nigg JT, Lewis K, Edinger T, Falk M. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry 2012;51(1):86-97.e8.
Norsk legemiddelhandbok. Foreningen for utgivelse av Norsk legemiddelhåndbok; 2013. Tilgjengelig fra: http:www.legemiddelhandboka.no
Ogden T, Amlund-Hagen K. Multisystemic treatment of serious behaviour problems in youth: Sustainability of effectiveness two years after intake. 2006;3:142-9.
Ogrim G, Hestad KA. Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: a randomized pilot study. J Child Adolesc Psychopharmacol 2013;23(7):448-57.
Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry 2009;48(5):501-10.
Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46(7):894-921.
Politte LC, Henry CA, McDougle CJ. Psychopharmacological interventions in autism spectrum disorder. Harv Rev Psychiatry 2014;22(2):76-92.
Popper CW. Single-micronutrient and broad-spectrum micronutrient approaches for treating mood disorders in youth and adults. Child Adolesc Psychiatr Clin N Am 2014;23(3):591-672.
Poulsen L, Jorgensen SL, Dalsgaard S, Bilenberg N. [Danish standardization of the attention deficit hyperactivity disorder rating scale]. Ugeskr Laeger 2009;171(18):1500-4.
Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K. How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry 2013;22(4):203-16.
Prevatt F, Yelland S. An Empirical Evaluation of ADHD Coaching in College Students. Journal of attention disorders 2015;19(8):666-77.
Roth R, Lance C, Isquith P, Fischer A, Giancola P. Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function-Adult version in healthy adults and application to attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol 2013;28(5):425-34.
Rucklidge JJ, Frampton CM, Gorman B, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 2014;204:306-15.
Rutter M, Bishop D, Pine D, Scott S, Stevenson E, Taylor E, et al., red. Rutter's Child and Adolescent Psychiatry. Blackwell Publishing; 2008.
Rutter M, Bishop D, Pine D, Scott S, Stevenson E, Taylor E, et al., red. Taylor E, Sounuga-Barke E. Disorders of Attention and Activity. In Rutter's Child and Adolescent Psychiatry. Blackwell Publishing; 2008.
Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications. CNS drugs 2005;19(8):643-55.
Siegel MS, Smith WE. Psychiatric features in children with genetic syndromes: toward functional phenotypes. Child Adolesc Psychiatr Clin N Am 2010;19(2):229-61, viii.
Sinus AB. STRATEGI-programmetNacka [oppdatert 2003; lest 8. oktober]. Tilgjengelig fra: http://sinus.se/strategi/default.asp
Slama H, Fery P, Verheulpen D, Vanzeveren N, Van Bogaert P. Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate. J Child Neurol 2015;30(8):1000-9.
Smith G, Jongeling B, Hartmann P, et al. Raine ADHD study: long-term outcomes associated with stimulant medication in the treatment of ADHD in children. Perth: Government of Western Australia Department of Health; 2010.
Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013;170(3):275-89.
Sonuga-Barke EJ, Koerting J, Smith E, McCann DC, Thompson M. Early detection and intervention for attention-deficit/hyperactivity disorder. Expert Rev Neurother 2011;11(4):557-63.
Statens beredning för medicinsk utvärdering (SBU). DHD hos flickor. En inventering av det vetenskaplige underlaget. 2005. Rapport nr. 174.
Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, et al. Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry 2014;55(5):416-27.
Storebo OJ, Simonsen E. Is ADHD an early stage in the development of borderline personality disorder? Nordic journal of psychiatry 2014;68(5):289-95.
Storebo OJ, Simonsen E. The Association Between ADHD and Antisocial Personality Disorder (ASPD): A Review.J Atten Disord. 2013 Nov 27. [Epub ahead of print]
Storebo OJ, Skoog M, Damm D, Thomsen PH, Simonsen E, Gluud C. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. The Cochrane database of systematic reviews 2011;(12):Cd008223.
Strand G, red. AD/HD, Tourettes syndrom og narkolepsi: en grunnbok. 2. utgave utg. Oslo: Fagbokforlaget; 2009.
Sundhedsstyrelsen. National klinisk retningslinje: ADHD. 2014. Tilgjengelig fra: http://sundhedsstyrelsen.dk/da/nyheder/2014/~/media/A7931B11333540A184C73465181E29CE.ashx
Suren P, Bakken IJ, Aase H, Chin R, Gunnes N, Lie KK, et al. Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children. Pediatrics 2012;130(1):e152-8.
Surman CB, Adamson JJ, Petty C, Biederman J, Kenealy DC, Levine M, et al. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study. J Clin Psychiatry 2009;70(11):1523-9.
Swanson J, Gupta S, Guinta D, Flynn D, Agler D, Lerner M, et al. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 1999;66(3):295-305.
Sykehuset Innlandet HF. Behandlingslinje for ADHD hos barn og unge i Hedmark og Oppland. 2014.
Sykehuset Østfold. Behandlingslinje for barn og unge med ADHD i Østfold. 2006.
Thapar A, Cooper M, Eyre O, Langley K. What have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013;54(1):3-16.
The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56(12):1073-86.
Tsang TW, Kohn MR, Efron D, Clarke SD, Clark CR, Lamb C, et al. Anxiety in young people with ADHD: clinical and self-report outcomes. Journal of attention disorders 2015;19(1):18-26.
van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 2014;134:158-66.
van Dongen-Boomsma M, Vollebregt MA, Slaats-Willemse D, Buitelaar JK. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2013;74(8):821-7.
van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 2014;109(2):262-72.
Vidal R, Bosch R, Nogueira M, Gomez-Barros N, Valero S, Palomar G, et al. Psychoeducation for adults with attention deficit hyperactivity disorder vs. cognitive behavioral group therapy: a randomized controlled pilot study. J Nerv Ment Dis 2013;201(10):894-900.
Webster-Stratton C, Reid MJ, Beauchaine TP. One-year follow-up of combined parent and child intervention for young children with ADHD. J Clin Child Adolesc Psychol 2013;42(2):251-61.
Webster-Stratton CH, Reid MJ, Beauchaine T. Combining parent and child training for young children with ADHD. J Clin Child Adolesc Psychol 2011;40(2):191-203.
Wichstrom L, Berg-Nielsen TS, Angold A, Egger HL, Solheim E, Sveen TH. Prevalence of psychiatric disorders in preschoolers. J Child Psychol Psychiatry 2012;53(6):695-705.
Wilens TE, Kwon A, Tanguay S, Chase R, Moore H, Faraone SV, et al. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005;14(4):319-27.
Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, et al. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011;50(6):543-53.
Wingo AP, Ghaemi SN. A systematic review of rates and diagnostic validity of comorbid adult attention-deficit/hyperactivity disorder and bipolar disorder. J Clin Psychiatry 2007;68(11):1776-84.
World Health Organization. International classification of diseases. [8th] ninth revision, basic tabulation list with alphabetic index utg. Geneva; 1965.
World Health Organization. Multiaxial Classification of Child and Adolescent Psychiatric Disorders. The ICD-10 Classification of Mental and Behavioural Disorders in Children and Adolescents. Geneva; 1996.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva; 1993.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Norsk utgave 1999 utg. Geneva; 1992.
Yanofski J. The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation? Innov Clin Neurosci 2011;8(1):47-53.
Young S, Khondoker M, Emilsson B, Sigurdsson JF, Philipp-Wiegmann F, Baldursson G, et al. Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis. Psychol Med 2015:1-12.
Zayats T, Athanasiu L, Sonderby I, Djurovic S, Westlye LT, Tamnes CK, et al. Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PLoS One 2015;10(4):e0122501.
Zeiner P, Backe-Hansen E, Eskeland S, Ogden T, Rypdal P, Sommerschild H. Barn og unge med alvorlige atferdsvansker. forskningsråd N; 2008.
Zeiner P, red. Barn og unge med ADHD. Vollen: Tell forlag; 2007.
Zulauf CA, Sprich SE, Safren SA, Wilens TE. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Current psychiatry reports 2014;16(3):436.


Sist faglig oppdatert: 13. juni 2018